http://www.stormcam.org/topo-national/
Cell Therapeutics Announces Agreement for Phase II Study of Pixantrone in Metastatic Breast Cancer
Cell Therapeutics, Inc. today announced an agreement with the North Central Cancer Treatment Group to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
Topo-Duo at National Falls Upper Yough